Publisher
Springer Berlin Heidelberg
Reference25 articles.
1. Agodoa L.Y., Appel L., Bakris G.L., Beck G., Bourgoignie J., Briggs J.P. et al. for the African American Study of Kidney Disease and Hypertension (AASK) Study Group (2001): Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial. JAMA 285: 2719–2728.
2. Arzneimittelkommission der deutschen Ärzteschaft (1997): Calciumantagonisten vom 1,4-Dihydropyridin-Typ. Dtsch. Ärztebl. 22: C-1122-C-1123.
3. Blood Pressure Lowering Treatment Trialists’ Collaboration (2000): Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 356: 1955–1964.
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L. Jr. et al. and the National High Blood Pressure Education Program Coordinating Committee (2003): The seventh report on the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289: 2560–2572.
5. Cohn J.N., Ziesche S.M., Loss L.E., Anderson G.F., V-HeFT Study Group (1995): Effect of felodipine on short-term exercise and neurohormone and long-term mortality in heart failure: Results of V-HeFT VIII. Circulation 92:1–143.